Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 3, 2003, Pages 592-597

  Kakinuma, Takashi ^a   Saeki, Hidehisa ^a   Tsunemi, Yuichiro ^a   Fujita, Hideki ^a   Asano, Noriko ^a   Mitsui, Hiroshi ^a   Tada, Yayoi ^a   Wakugawa, Motoshi ^a   Watanabe, Takahiro ^a   Torii, Hideshi ^a   Komine, Mayumi ^a   Asahina, Akihiko ^a   Nakamura, Koichiro ^b   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; CCL27; Cutaneous T cell attracting chemokine; Disease activity; Psoriasis vulgaris

Indexed keywords

BETA CHEMOKINE; CCL27 CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 2 RECEPTOR; MACROPHAGE DERIVED CHEMOKINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS VULGARIS; SCORING SYSTEM; SKIN DISEASE; SKIN INFLAMMATION; TISSUE LEVEL;

EID: 0037339154     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.114     Document Type: Article

References (20)

1. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venerol Suppl (Stock) 1980;92(suppl):44-7.
2. Leung DYM. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000;105:860-76.
3. Kapp A, Piskorski A, Schopf E. Elevated levels of interleukin 2 receptor in sera of patients with atopic dermatitis. Br J Dermatol 1988;119:707-10.
4. Yamashita N, Kaneko S, Kouno O, Furue M, Yamamoto S, Sakane T. Soluble E-selectin as a marker of disease activity in atopic dermatitis. J Allergy Clin Immunol 1997;99:410-6.
5. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001;107:535-41.
6. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, et al. Serum macrophage-derived chemokines are closely related with the disease activity of atopic dermatitis. Clin Exp Immunol 2002;127:270-3.
7. Valdimarsson H, Baker BS, Jonsdottir H, Fry L. Psoriasis - a disease of abnormal proliferation induced by T lymphocytes. Immunol Today 1986;16:256-9.
8. Chang E, Hammerberg C, Fisher G, Baadsgaard O, Ellis CN, Voorhees JJ, et al. T-cell activation is potentiated by cytokines released by lesional psoriatic, but not normal, epidermis. Arch Dermatol 1995;128:1479-85.
9. Morales J, Homey B, Vicari AP, Hudak S, Oldham E, Hedrick J, et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Pro Natl Acad Sci U S A 1999;96:14470-5.
10. Ishikawa-Mochizuki I, Kitaura M, Baba M, Nakayama T, Izawa D, Imai T, et al. Molecular cloning of a novel CC chemokine, interleukin-11 receptor a-locus chemokine (ILC), which is located on chromosome 9p 13 and a potential homologue of a CC chemokine encoded by molluscum contagiosum virus. FEBS Lett 1999;460:544-8.
11. Kunkel EJ, Butcher EC. Chemokines and the tissue-specific migration of lymphocytes. Immunity 2002;16:1-4.
12. Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC. CC chemokine receptor (CCR) 4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 2001;194:1541-7.
13. Homey B, Wang W, Soto H, Buchanan ME, Wiesenborn A, Catron D, et al. THe orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol 2000;164:3465-70.
14. Homey B, Alenius H, Muller A, Soto H, Bowman EP, Yuan W, et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002;8:157-65.
15. Eumpian Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 1993;186:23-31.
16. Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taieb A. Clinical varidation and guidelines for the SCORAD index: consensus report of the Europian Task Force on Atopic Dermatitis. Dermatology 1997;195:10-9.
17. Giustizieri ML, Mascia F, Frezzolini A, De Pita O, Chinni LM, Giannetti A, et al. Keratinocytes from patients with atopic dermatitis and psoriasis vulgaris show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol 2001;107:871-7.
18. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 1994;55:97-179.
19. Stoof TJ, Flier J, Sampat S, Nieboer C, Tensen CP, Boorsma DM. The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells. Br J Dermatol 2001;144:1114-20.
20. Fredriksson T, Pettersson U. Severe psoriasis - oral thempy with a new retinoid. Dermatologica 1978;157:238-44.